We evaluated the effectiveness and pra cticality of using AlioD erm, an 
Introduction
Parotidectomy creates a cos metic deformity belo w the ear. Oftentim es, nothing is done to repair this defect because it is not particul arly noticeable in a full-face view. However, it is noticeable from oblique and lateral perspectives as a depression below the ear and posterior to the mandibl e, and this is bothersome to some patients.
Several method s have been attempted to amelio rate this defect, includin g the creation of various sternomastoid flaps and the transfer of tissue such as fat. We condu cted a study to assess the value of using an AlloDerm (LifeCell Corp .; Branchburg, N.J .) graft to fill in the surgical defect and improve the cosmesis of the surgical site in postparotidectomy patients . AlloDerm is an acellular hum an dermal matrix that is used as an implant for soft-tissue support and contouring. It is deri ved from cadaver ic skin that has been scree ned for human immun odeficiency virus, hepatit is B and C viruses, hum an T-Iymph otropic virus type I, and syphilis.AlloDerm does not elicit an immun e response after placement because the epidermis and all cellular components are remov ed during processing. The biochemical and structural properties of collagen type IV that is retained in the derma l matrix make AlloDerm useful as a soft-tissue replacement. This particular use of AlloDerm grew out of an earlier study at our institution in which we eva luated its effectiveness in preventing Frey syndro me.J 
Patients and methods
Our study population was made up of 10 patients--4 men and 6 women , aged 37 to 69 years (mean: 52)-who had undergone superficial parotidectomy. Folded sheets of AlloD erm were used to reconstruct the soft-tissue defect created by the surge ry. Once a satisfactory contour was achieved, a thick graft (900 urn) was used to cover the entire parotid bed.
The graft was sutured to the masseter muscle ante riorly, to the zygo matic arch superiorly, to the sternocleidomastoid muscle posteroinferiorly, to the tragal perichondrium preauricularly, and to the mastoid perios teum postauricularly.
Results
All 10 patients exhib ited exce llent cos metic results as viewed from frontal, lateral, and oblique perspectives. Facial nerve function was normal in all patients despite the fact that the AlloD erm had been applied directly over the nerve branches, which prevented any potential blood supply from reaching the flaps. The only postoperative complication was tran sient seroma in 3 patients; all of the sero mas resolved with in I week following aspiration, with or without the application of a pressure dressing . The excellent cosmetic results were maintain ed at the I-year follow-up (figure).
Discussion
In addition to being a low-risk procedur e, AlloDerm grafting offers several advantages over alternate method s of achieving the same goal. AlloDerm is readily ava ilable and easy to work with, and its appli cation does not significantly increase operative time. It readily integrates with recipient tissue, and the risk of ext rus ion is low. Finally, AlloDerm does not produce donor-site morbidity as do autoge nous interpositional barriers such as fat.
Among the charac teristics of other procedures:
• An inferiorly based sternoc leidomas toid muscl e flap is one exa mple of an autoge nous interpositio nal barri er that has been shown to imp rove cosmetic outc omes after parotidect omy.' However, plac ement of such a flap not only requires more ope rativ e time, but it is also associated with cert ain postsurgical complications, such as dimin ished function of the greater auricular nerve.
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Moreover, it does not objectively lower the incidence of Frey syndrome, as does the use of AlloDerm.I
• Interposition of a temporoparietal fascia flap(TPFF)-a thin, fan-shaped, highly vascular flap that is pedicled on the superficial temporal artery-is another autologous graft procedure that has been used to correc t the deformity created by parotidectomy.' Its advantages over other autologous flaps include (1) its ability to confor m to the contour of the cheek and (2) site to the parotid bed, which means that the surgeon need make only one incision. A disadva ntage associated with the use of a TPFF is the risk of injury to the frontal branch of the facial nerve.
• Another reco nstruction technique involves the use of a flap made up of three elements: platysma muscle, cervical fascia, and sternocleidomastoid muscle (PCS). In a retrospective evaluation, Kim and Mathog reported that patients who received a PCS flap achieved better overall cosmesis and expressed greater overall satisfaction than did patients who did not receive such a flap.' However, several of the 9 patient s who were treated with the PCS flap reported a mild fullness on the operated side, and 2 noted some degree of neck deformity.
• Finally, reconstruction has been performed with an expanded polytef (polytetrafluoroethy lene [ePTFE]) softtissue patch." The ePTFE is a synthetic biomaterial that acts as a structural lattice for the overlying skin and the underlying fibrosis that fills the defect, thereb y creating a nearly normal contour despite being only 1 to 2 mm thick. The advantages of this biomaterial are similar to those of AlloDerm-that is, the ePTFE patch does not evoke a foreign-body response, it is readily available, and it is easily trimmed and sutured.
The cost of AlloDerm for any particular operation depends on the number and size of the grafts that are necessary, but we estimate that it would average approximately$1,000. Although we have not performed a formal cost analysis, we believe that the cost of the AlloDe rm would be offset by the lower costs associated with the shorter amount of operating time that this procedure requires relative to the other techniques.
One concern with postparotidectomy reconstruction with AlloDerm-or any interpositional barrier, for that matter-is that it may mask the recurrence of a high-grade malignancy. Therefore, it is recommended that patients be followed for 2 years following parotidectomy before placement of AlloDerm is considered.
In summation, we conclud e that the use of an AlloDerm implant is a low-risk, practical option for repairing the surgical defect in postparotidectomy patients.
